InfuSystems Holdings, Inc. (INFU): Price and Financial Metrics


InfuSystems Holdings, Inc. (INFU): $8.49

0.04 (+0.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

INFU POWR Grades


  • Stability is the dimension where INFU ranks best; there it ranks ahead of 82.76% of US stocks.
  • The strongest trend for INFU is in Growth, which has been heading up over the past 179 days.
  • INFU ranks lowest in Momentum; there it ranks in the 38th percentile.

INFU Stock Summary

  • INFU has a higher market value than only 23.1% of US stocks; more precisely, its current market capitalization is $200,338,291.
  • INFU's current price/earnings ratio is 141.08, which is higher than 95.75% of US stocks with positive earnings.
  • Of note is the ratio of InfuSystem Holdings Inc's sales and general administrative expense to its total operating expenses; 84.55% of US stocks have a lower such ratio.
  • If you're looking for stocks that are quantitatively similar to InfuSystem Holdings Inc, a group of peers worth examining would be PRFT, MEDP, RGR, GLOB, and DCO.
  • Visit INFU's SEC page to see the company's official filings. To visit the company's web site, go to www.infusystem.com.

INFU Valuation Summary

  • INFU's price/sales ratio is 3; this is 73.57% lower than that of the median Healthcare stock.
  • Over the past 167 months, INFU's price/sales ratio has gone NA NA.
  • Over the past 167 months, INFU's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for INFU.

Stock Date P/S P/B P/E EV/EBIT
INFU 2021-08-31 3.0 6.6 19.4 57.2
INFU 2021-08-30 2.9 6.5 19.3 56.8
INFU 2021-08-27 3.0 6.5 19.4 57.1
INFU 2021-08-26 3.0 6.7 19.8 58.1
INFU 2021-08-25 3.1 6.8 20.2 59.3
INFU 2021-08-24 3.1 7.0 20.7 60.5

INFU Growth Metrics

    The 3 year price growth rate now stands at 28.77%.
  • Its 5 year cash and equivalents growth rate is now at -46.4%.
  • Its 3 year net income to common stockholders growth rate is now at -148.55%.
INFU's revenue has moved up $33,534,000 over the prior 34 months.

The table below shows INFU's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 102.382 18.316 1.42
2021-09-30 100.574 22.217 11.703
2021-06-30 99.133 24.832 15.091
2021-03-31 100.298 22.374 18.411
2020-12-31 97.388 20.28 17.332
2020-09-30 94.387 17.009 7.467

INFU's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • INFU has a Quality Grade of B, ranking ahead of 82.85% of graded US stocks.
  • INFU's asset turnover comes in at 1.09 -- ranking 17th of 186 Medical Equipment stocks.
  • ADMT, BLFS, and ESMC are the stocks whose asset turnover ratios are most correlated with INFU.

The table below shows INFU's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.090 0.603 0.060
2021-03-31 1.140 0.605 0.102
2020-12-31 1.133 0.603 0.097
2020-09-30 1.157 0.601 0.103
2020-06-30 1.121 0.593 0.087
2020-03-31 1.082 0.582 0.049

INFU Stock Price Chart Interactive Chart >

Price chart for INFU

INFU Price/Volume Stats

Current price $8.49 52-week high $21.89
Prev. close $8.45 52-week low $6.78
Day low $8.27 Volume 63,300
Day high $8.60 Avg. volume 127,322
50-day MA $9.01 Dividend yield N/A
200-day MA $13.37 Market Cap 174.38M

InfuSystems Holdings, Inc. (INFU) Company Bio


InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was founded in 2005 and is headquartered in Madison Heights, Michigan.


INFU Latest News Stream


Event/Time News Detail
Loading, please wait...

INFU Latest Social Stream


Loading social stream, please wait...

View Full INFU Social Stream

Latest INFU News From Around the Web

Below are the latest news stories about InfuSystem Holdings Inc that investors may wish to consider to help them evaluate INFU as an investment opportunity.

InfuSystem Inks Distribution Pact For Solo-Dex''s Continuous Peripheral Nerve Block Catheters

InfuSystem Holdings Inc (NYSE: INFU ) has announced a national distribution agreement with Solo-Dex Inc for its proprietary continuous nerve block catheters. With Solo-Dex catheter over the needle technology, all anesthesiologists can place facile Full story available on Benzinga.com

Benzinga | February 22, 2022

InfuSystem, Solo-Dex ink distribution deal for nerve block catheters for pain management

InfuSystem (INFU) signed a national distribution agreement with Solo-Dex for its proprietary continuous nerve block catheters

Seeking Alpha | February 22, 2022

InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters

ROCHESTER HILLS, Mich., February 22, 2022--InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters

Yahoo | February 22, 2022

InfuSystem: A Possible Goldmine After Recent Stumble

No summary available.

Seeking Alpha | February 21, 2022

InfuSystems Holdings: Q4 Earnings Insights

InfuSystems Holdings (AMEX: INFU ) reported its Q4 earnings results on Thursday, February 10, 2022 at 06:00 AM. Here''s what investors need to know about the announcement. Check out this: Insiders Buy Over $43M Of 4 Stocks Earnings InfuSystems Holdings missed estimated earnings … Full story available on Benzinga.com

Benzinga | February 10, 2022

Read More 'INFU' Stories Here

INFU Price Returns

1-mo 3.92%
3-mo -21.17%
6-mo -52.49%
1-year -57.80%
3-year 75.78%
5-year 553.08%
YTD -50.15%
2021 -9.32%
2020 120.16%
2019 147.97%
2018 49.57%
2017 -9.80%

Continue Researching INFU

Want to see what other sources are saying about InfuSystem Holdings Inc's financials and stock price? Try the links below:

InfuSystem Holdings Inc (INFU) Stock Price | Nasdaq
InfuSystem Holdings Inc (INFU) Stock Quote, History and News - Yahoo Finance
InfuSystem Holdings Inc (INFU) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7293 seconds.